High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.5M
$7,530,148
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-23
$351,000x2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-23 | $351,000x2 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -95.7%
2025-12-23
$2,752,419Large
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -95.7%
|
2025-12-23 | $2,752,419Large | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-22
$703,392x4
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-22 | $703,392x4 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -64.9%
2025-12-22
$2,804,000Large
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -64.9%
|
2025-12-22 | $2,804,000Large | S | Form 4 |
|
OLMA
M
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Equity Compensation
2025-12-19
$610,000x2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-19 | $610,000x2 | M | Form 4 |
|
OLMA
S
Olema Pharmaceuticals, Inc.
Zojwalla Naseem
• Officer • Chief Medical Officer
Discretionary SellΔOwn -11.1%
2025-12-19
$1,973,729Largex2
|
||||||
| OLMA |
Olema Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Discretionary SellΔOwn -11.1%
|
2025-12-19 | $1,973,729Largex2 | S | Form 4 |